- Home
- GNLX vs TKNO Comparison
GNLX vs TKNO Comparison
Compare GNLX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | TKNO |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 138.1M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GNLX | TKNO |
|---|---|---|
| Price | $2.62 | $3.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 225.3K | 107.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.47 | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | $8,000.00 | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $2.26 | $1.91 |
| 52 Week High | $8.54 | $7.48 |
Technical Indicators
Market Signals| Indicator | GNLX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.06 | 57.42 |
| Support Level | $2.40 | $3.01 |
| Resistance Level | $3.00 | $3.24 |
| Average True Range (ATR) | 0.22 | 0.24 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 55.83 | 67.61 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.